Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-26

FDA Approved: GANCICLOVIR — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for ganciclovir sodium (generic ganciclovir) submitted by Hikma Pharmaceuticals USA Inc., under ANDA 076222.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

SUPPL AP for GANCICLOVIR (GANCICLOVIR SODIUM)